SCHEMBL5502435

SCHEMBL5502435

COCCSc1ncnc2cc(OCc3ccccc3)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.46
CYP3A4 P08684 1/20 0.45
EGFR P00533 4/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 1/20 0.45
KDR P35968 1/20 0.45
KMT2A Q03164 1/20 0.45
HTT P42858 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ERBB2 P04626 3/20 0.43
KDM1A O60341 3/20 0.43
STK17B O94768 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41
MAOB P27338 1/20 0.41
CHEK2 O96017 1/20 0.40
ROS1 P08922 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4421697 0.83 MEN1 (0.49) KITCYP3A4EGFRMAPTMEN1
SCHEMBL27904633 0.73 PRMT5 (0.57) KITCYP3A4EGFRMAPTMEN1
SCHEMBL5465811 0.73 MEN1 (0.55) KITCYP3A4EGFRMAPTMEN1
SCHEMBL856483 0.73 CYP3A4 (0.51) KITCYP3A4EGFRMAPTMEN1
SCHEMBL4728679 0.72 KIT (0.56) KITCYP3A4EGFRMAPTMEN1
Hydrochloric Acid SCHEMBL7211024 0.72 CYP3A4 (0.50) KITCYP3A4EGFRMAPTMEN1
SCHEMBL4728722 0.72 ADORA2A (0.53) KITCYP3A4EGFRMAPTMEN1
SCHEMBL5493935 0.72 BRAF (0.44) KITFLT3AURKB
SCHEMBL7982589 0.71 CSF1R (0.57) KITEGFRMAPTMEN1KDR
Alcohol SCHEMBL27887820 0.71 PRMT5 (0.52) KITCYP3A4EGFRMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed
EP-1005470-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010349-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 1999-03-04 WO disclosed